The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,716,015 in first-year total cost, median $732,288.
Most frequent study sections
- Special Emphasis Panel[ZRG1 ETTN-C (10)]1
- Special Emphasis Panel[ZRG1 ETTN-M (11)]1
- Special Emphasis Panel[ZRG1 MOSS-V (15)]1
Most frequent institutions
- BRAIN ELECTROPHYSIOLOGY LABORATORY COMPANY, LLC1
- RECOVR, INC.1
- REVERAGEN BIOPHARMA, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Improving Spatiotemporal Precision in Noninvasive Electrical Neuromodulation1R44MH115955-01 | TUCKER, DON M | BRAIN ELECTROPHYSIOLOGY LABORATORY COMPANY, LLC, OR | $732,288 | ZRG1 |
| 2016 | Phase IIa study of VBP15 for Duchenne muscular dystrophy1R44NS095423-01 | CLEMENS, PAULA RHOFFMAN, ERIC P. | REVERAGEN BIOPHARMA, INC., MD | $1,495,253 | ZRG1 |
| 2016 | Establishing the Functional Viability and Dose-Response of Duck, Duck Punch: A Stroke Rehabilitation Computer Game1R44NS097061-01A1 | HAYES, AUSTEN LUKEWOODBURY, MICHELLE LYNNE | RECOVR, INC., SC | $488,474 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.